Completed Clinical Trials

A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma.

By April 24, 2017 No Comments



Estimated Enrollment: 22

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Intervention Model: Single Group Assignment|Masking: No masking|Primary Purpose: Treatment

Study ID Numbers: 2009/337

Study First Received: October 15, 2009

Last Updated: February 7, 2017

Estimated Primary Completion Date: September 2015


Primary Outcome Measures:

Progression fee survival rate|Response rate according to modified RECIST criteria|Toxicity (CTCAE version 4)|Overall survival

Sponsors and Collaborators:

University Hospital, Ghent|Merck Sharp & Dohme Corp.

Website Link:

Leave a Reply

Call Now ButtonCall Now